×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CMND – clearmind medicine inc. - common shares (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CMND
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/4
07:51 am
cmnd
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval [Yahoo! Finance]
Medium
Report
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval [Yahoo! Finance]
3/4
07:30 am
cmnd
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
High
Report
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
2/19
01:05 pm
cmnd
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss?
Medium
Report
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss?
2/9
08:17 am
cmnd
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial
High
Report
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial
2/6
07:55 am
cmnd
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
High
Report
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
2/3
08:00 am
cmnd
Excellent Achievements for Clearmind’s Proprietary MEAI that was Included in U.S. Congress’ Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments
High
Report
Excellent Achievements for Clearmind’s Proprietary MEAI that was Included in U.S. Congress’ Emerging Therapies Bill to Expand Veteran Access to Innovative Treatments
1/20
06:21 pm
cmnd
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025 [Yahoo! Finance]
Low
Report
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025 [Yahoo! Finance]
1/20
04:20 pm
cmnd
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
Medium
Report
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/4
09:01 am
cmnd
Form 6-K Clearmind Medicine Inc. For: Mar 04
Medium
Report
Form 6-K Clearmind Medicine Inc. For: Mar 04
2/27
06:13 am
cmnd
Form EFFECT Clearmind Medicine Inc.
Low
Report
Form EFFECT Clearmind Medicine Inc.
2/17
04:47 pm
cmnd
Form F-3 Clearmind Medicine Inc.
Low
Report
Form F-3 Clearmind Medicine Inc.
2/17
04:44 pm
cmnd
Form 6-K Clearmind Medicine Inc. For: Feb 17
Low
Report
Form 6-K Clearmind Medicine Inc. For: Feb 17
2/17
10:49 am
cmnd
Form SCHEDULE 13G/A Clearmind Medicine Inc. Filed by: Iroquois Capital Management, LLC
High
Report
Form SCHEDULE 13G/A Clearmind Medicine Inc. Filed by: Iroquois Capital Management, LLC
2/11
04:16 pm
cmnd
Form 6-K Clearmind Medicine Inc. For: Feb 11
Medium
Report
Form 6-K Clearmind Medicine Inc. For: Feb 11
2/9
08:19 am
cmnd
Form 6-K Clearmind Medicine Inc. For: Feb 09
High
Report
Form 6-K Clearmind Medicine Inc. For: Feb 09
2/6
09:53 am
cmnd
Form 6-K Clearmind Medicine Inc. For: Feb 06
Medium
Report
Form 6-K Clearmind Medicine Inc. For: Feb 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: